We performed a multistage genome-wide association study including 7,683 individuals with
pancreatic cancer and 14,397 controls of European descent. Four new loci reached genome …

We conducted a genome-wide association study of pancreatic cancer in 3,851 affected
individuals (cases) and 3,934 unaffected controls drawn from 12 prospective cohort studies …

Pancreatic cancer has the lowest survival rate among human cancers, and there are no
effective markers for its screening and early diagnosis. To identify genetic susceptibility …

Pancreatic cancer is the fourth leading cause of cancer death in the developed world. Both
inherited high-penetrance mutations in BRCA2 (ref.), ATM, PALB2 (ref.), BRCA1 (ref.) …

Background Although 20 pancreatic cancer susceptibility loci have been identified through
genome-wide association studies in individuals of European ancestry, much of its heritability …

Genome-wide association studies (GWAS) have identified common pancreatic cancer
susceptibility variants at 13 chromosomal loci in individuals of European descent. To identify …

Abstract In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe
and the United States combined. To identify common susceptibility alleles, we performed the …

Pancreatic cancer is the fifth leading cause of cancer death in the United States. Nearly
every person diagnosed with pancreatic cancer will die from it, usually in< 6 mo. Familial …

Pancreatic cancer is projected to become the second leading cause of cancer-related death
in the United States by 2020. A familial aggregation of pancreatic cancer has been …

We have organized the Pancreatic Cancer Genetic Epidemiology (PACGENE) Consortium
to identify susceptibility genes in familial pancreatic cancer (FPC). The Consortium …